1) 村山繁雄,齊藤祐子,文村優一,他:東京都高齢者ブレインバンクの創設.Dementia Jpn 18:54-63, 2004
2) 村山繁雄,齊藤祐子,金丸和富,他:ブレインバンクの構築と課題.日本老年医学会雑誌 42:483-489, 2005
3) Saito Y, Ruberu NN, Sawabe M, et al:Lewy body-related alpha-synucleinopathy in aging. J Neuropath Exp Neurol 63:742-749, 2004
4) Saito Y, Ruberu NN, Sawabe M, et al:Staging of argyrophilic grains, an age-associated tauopathy. J Neuropath Exp Neurol 63:911-918, 2004
5) 村山繁雄,齊藤祐子,笠畑尚喜:軽度認知機能障害の神経病理.神経研究の進歩 48:441-449, 2004
6) Braak H, Braak E:Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259, 1991
7) Braak H, Alafuzoff I, Arzberger T, et al:Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 2006 Epub
8) Mirra SS, Heyman A, McKeel D, et al:The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486, 1991
9) McKeith IG, Galasko D, Kosaka K, et al:Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB):report of the consortium on DLB international workshop. Neurology 47:1113-1124, 1996
10) McKeith IG, Dickson DW, Lowe J, et al:Diagnosis and management of dementia with Lewy bodies:third report of the DLB Consortium. Neurology 65:1863-1867, 2005
11) Braak H, Alafuzoff I, Arzberger T, et al:Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) on line
12) Murayama S, Saito Y:Neuropathological diagnostic criteria for Alzheimer disease. Neuropathology 24:254-260, 2004
13) Mizuta I, Satake W, Nakabayashi Y, et al:Multiple candidate gene analysis identifies a-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Gen 15:1151-1158, 2006